Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage (2022)
- Authors:
- USP affiliated authors: NOGUEIRA, JONATAS EVANDRO - EEFERP ; BRANCO, LUIZ GUILHERME DE SIQUEIRA - FORP ; SILVA, ADELINO SANCHEZ RAMOS DA - EEFERP ; PINTO, ANA PAULA - EEFERP ; ROCHA, ALISSON LUIZ DA - FMRP ; MARAFON, BRUNO BRIEDA - EEFERP
- Unidades: EEFERP; FORP; FMRP
- DOI: 10.1111/1440-1681.13677
- Subjects: DEGRANULAÇÃO CELULAR; INFLAMAÇÃO; INTERLEUCINA 6; EXERCÍCIO FÍSICO
- Keywords: Autophagy; Exercise; Liver; mTORC1; Rapamycin
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical and Experimental Pharmacology and Physiology
- ISSN: 0305-1870
- Volume/Número/Paginação/Ano: v. 49, n. 8, p. 893-902, 2022
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PINTO, Ana Paula et al. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage. Clinical and Experimental Pharmacology and Physiology, v. 49, n. 8, p. 893-902, 2022Tradução . . Disponível em: https://doi.org/10.1111/1440-1681.13677. Acesso em: 27 abr. 2024. -
APA
Pinto, A. P., Rocha, A. L. da, Marafon, B. B., Nogueira, J. E., Branco, L. G. de S., Pauli, J. R., et al. (2022). Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage. Clinical and Experimental Pharmacology and Physiology, 49( 8), 893-902. doi:10.1111/1440-1681.13677 -
NLM
Pinto AP, Rocha AL da, Marafon BB, Nogueira JE, Branco LG de S, Pauli JR, Moura LP de, Cintra DE, Ropelle ER, Silva ASR da. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage [Internet]. Clinical and Experimental Pharmacology and Physiology. 2022 ; 49( 8): 893-902.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/1440-1681.13677 -
Vancouver
Pinto AP, Rocha AL da, Marafon BB, Nogueira JE, Branco LG de S, Pauli JR, Moura LP de, Cintra DE, Ropelle ER, Silva ASR da. Chronic rapamycin treatment decreases hepatic IL‐6 protein, but increases autophagy markers as a protective effect against the overtraining‐induced tissue damage [Internet]. Clinical and Experimental Pharmacology and Physiology. 2022 ; 49( 8): 893-902.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/1440-1681.13677 - Hepatic LC3 II/I ratio is not modulated in exercised mice
- Muscle endoplasmic reticulum stress in exercise
- Impact of different physical exercises on the expression of autophagy markers in mice
- The combination of fasting, acute resistance exercise, and protein ingestion led to different responses of autophagy markers in gastrocnemius and liver samples
- Moderate, but not excessive, training attenuates autophagy machinery in metabolic tissues
- FOXO1 is downregulated in obese mice subjected to short‐term strength training
- Role of TLR4 in physical exercise and cardiovascular diseases
- Physical exercise and liver autophagy: potential roles of IL-6 and irisin
- Short-term combined exercise improves inflammatory profile in the retina of obese mice
- Role of interleukin-6 in inhibiting hepatic autophagy markers in exercised mice
Informações sobre o DOI: 10.1111/1440-1681.13677 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
